Fifteen Israeli companies are expected to come together, May 6-7, with major U.S. stakeholders in Neurotechnology to explore business and research relationships at the
US-Israel Neurotechnology Business Exchange.
Hosted by the Medical University of South Carolina (MUSC) in Charleston, South Carolina, the event offers a focused opportunity for them to present their technologies and have pre-arranged meetings with leading pharmaceutical, diagnostic, and device companies, healthcare institutions, and investors in North America with the goal of fostering joint venture R&D, investment, and marketing alliances.
Organized by the Medical Committee and the South Carolina-Israel Collaboration of the American-Israel Chamber of Commerce, Southeast Region, Israel Economic Mission NY, and the BIRD Foundation and Israel Brain Technologies in Israel, the two-day event is built on the premise that the United States remains one of the major hubs for innovation, development, and commercialization of new products for the diagnosis and treatment of brain disorders, and Israeli companies working in this field have seen that the presence in the US is a critical step for success with its innovation and proven track record in fields such as computer science, nanotechnology and brain research.
Click here for the event website
In addition to the MUSC, other sponsors to date include Womble Carlyle, CRDA, The InterTech Group, Consulate General of Israel to the Southeast; Israel Association of Technology Industries, SCBio, University of South Carolina, and Clemson University.
Contact: Tom Glaser, 404-843-9426, email@example.com